Atossa Therapeutics, Inc. (BMV:ATOS)
Mexico
· Delayed Price · Currency is MXN 17.20
0.00 (0.00%)
Last updated: May 12, 2025
Atossa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 65.12 | 71.08 | 88.46 | 110.89 | 136.38 | 39.55 | Upgrade
|
| Cash & Short-Term Investments | 65.12 | 71.08 | 88.46 | 110.89 | 136.38 | 39.55 | Upgrade
|
| Cash Growth | -22.44% | -19.64% | -20.23% | -18.69% | 244.79% | 214.39% | Upgrade
|
| Other Receivables | - | - | - | 0.74 | 1.07 | 0.64 | Upgrade
|
| Receivables | - | - | - | 0.74 | 1.07 | 0.64 | Upgrade
|
| Inventory | 2.08 | 2.1 | 1.49 | 5.25 | - | - | Upgrade
|
| Prepaid Expenses | 1.44 | 0.7 | 1.3 | 1.21 | 2.49 | 1.81 | Upgrade
|
| Restricted Cash | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | Upgrade
|
| Other Current Assets | - | 0.47 | 0.87 | - | 1.19 | 0.66 | Upgrade
|
| Total Current Assets | 68.74 | 74.46 | 92.22 | 118.2 | 141.24 | 42.77 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0.04 | Upgrade
|
| Long-Term Investments | - | - | 1.71 | 4.7 | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 0.01 | Upgrade
|
| Other Long-Term Assets | 2 | 1.99 | 2.32 | 0.64 | 0.02 | 0.02 | Upgrade
|
| Total Assets | 70.75 | 76.44 | 96.25 | 123.53 | 141.26 | 42.84 | Upgrade
|
| Accounts Payable | 1.17 | 0.68 | 0.81 | 2.97 | 1.72 | 1.59 | Upgrade
|
| Accrued Expenses | 2.73 | 2.78 | 2.63 | 2.58 | 1.39 | 1.06 | Upgrade
|
| Current Portion of Leases | - | - | - | - | - | 0.02 | Upgrade
|
| Other Current Liabilities | 1.53 | 1.51 | 1.8 | 0.02 | 0.02 | 13.01 | Upgrade
|
| Total Current Liabilities | 5.43 | 4.97 | 5.24 | 5.57 | 3.13 | 15.67 | Upgrade
|
| Total Liabilities | 5.43 | 4.97 | 5.24 | 5.57 | 3.13 | 15.67 | Upgrade
|
| Common Stock | 23.49 | 23.49 | 22.79 | 22.79 | 22.79 | 8.56 | Upgrade
|
| Additional Paid-In Capital | 261.82 | 261.26 | 255.99 | 251.37 | 244 | 129.89 | Upgrade
|
| Retained Earnings | -218.51 | -211.79 | -186.29 | -156.19 | -129.23 | -111.9 | Upgrade
|
| Treasury Stock | -1.48 | -1.48 | -1.48 | - | - | - | Upgrade
|
| Total Common Equity | 65.32 | 71.48 | 91.02 | 117.96 | 137.55 | 26.55 | Upgrade
|
| Shareholders' Equity | 65.32 | 71.48 | 91.02 | 117.96 | 138.14 | 27.17 | Upgrade
|
| Total Liabilities & Equity | 70.75 | 76.44 | 96.25 | 123.53 | 141.26 | 42.84 | Upgrade
|
| Total Debt | - | - | - | - | - | 0.02 | Upgrade
|
| Net Cash (Debt) | 65.12 | 71.08 | 88.46 | 110.89 | 136.38 | 39.54 | Upgrade
|
| Net Cash Growth | -22.44% | -19.64% | -20.23% | -18.69% | 244.94% | 215.51% | Upgrade
|
| Net Cash Per Share | 0.51 | 0.56 | 0.70 | 0.88 | 1.17 | 3.50 | Upgrade
|
| Filing Date Shares Outstanding | 129.17 | 129.17 | 125.3 | 126.62 | 126.62 | 120.82 | Upgrade
|
| Total Common Shares Outstanding | 129.17 | 129.17 | 125.3 | 126.62 | 126.62 | 47.55 | Upgrade
|
| Working Capital | 63.32 | 69.49 | 86.98 | 112.63 | 138.11 | 27.1 | Upgrade
|
| Book Value Per Share | 0.51 | 0.55 | 0.73 | 0.93 | 1.09 | 0.56 | Upgrade
|
| Tangible Book Value | 65.32 | 71.48 | 91.02 | 117.96 | 137.55 | 26.53 | Upgrade
|
| Tangible Book Value Per Share | 0.51 | 0.55 | 0.73 | 0.93 | 1.09 | 0.56 | Upgrade
|
| Machinery | - | - | - | - | - | 0.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.